Literature DB >> 19041940

Ceramide 1-phosphate (C1P) promotes cell migration Involvement of a specific C1P receptor.

María H Granado1, Patricia Gangoiti, Alberto Ouro, Lide Arana, Monika González, Miguel Trueba, Antonio Gómez-Muñoz.   

Abstract

Ceramide 1-phosphate (C1P) is a bioactive sphingolipid that is implicated in the regulation of cell homeostasis and the control of inflammation. It is mitogenic for fibroblasts and macrophages, and has been described as potent inhibitor of apoptosis. Using RAW 264.7 macrophages we have now discovered a new biological activity of C1P: stimulation of cell migration. This novel action can only be observed when C1P is applied exogenously to the cells in culture, and not by increasing the intracellular levels of C1P. This fact led to identify a specific receptor through which C1P stimulates cell migration. The receptor is coupled to G(i) proteins and causes phosphorylation of extracellularly regulated kinases 1 and 2, and protein kinase B (also known as Akt) upon ligation with C1P. Inhibition of either of these pathways completely abolished C1P-stimulated macrophage migration. In addition, C1P stimulated the DNA binding activity of nuclear factor kappa B, and blockade of this transcription factor resulted in complete inhibition of macrophage migration. This newly identified receptor could be an important drug target for treatment of illnesses that are associated to inflammatory processes, or to diseases in which cell migration is a major cause of pathology, as it occurs in metastatic tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19041940     DOI: 10.1016/j.cellsig.2008.11.003

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  53 in total

1.  A ceramide analog inhibits cPLA(2) activity and consequent PGE(2) formation in LPS-stimulated macrophages.

Authors:  Meir Goldsmith; Ala Daka; Nadia F Lamour; Roi Mashiach; Yifat Glucksam; Michael M Meijler; Charles E Chalfant; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2010-10-30       Impact factor: 3.685

2.  Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.

Authors:  Hiroyuki Kanzaki; Alexandru Movila; Rayyan Kayal; Marcelo H Napimoga; Kenji Egashira; Floyd Dewhirst; Hajime Sasaki; Mohammed Howait; Ayman Al-Dharrab; Abdulghani Mira; Xiaozhe Han; Martin A Taubman; Frank C Nichols; Toshihisa Kawai
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-01-31       Impact factor: 4.698

3.  Exogenous ceramide-1-phosphate (C1P) and phospho-ceramide analogue-1 (PCERA-1) regulate key macrophage activities via distinct receptors.

Authors:  Sebastián Katz; Orna Ernst; Dorit Avni; Muhammad Athamna; Amir Philosoph; Lide Arana; Alberto Ouro; L Alexis Hoeferlin; Michael M Meijler; Charles E Chalfant; Antonio Gómez-Muñoz; Tsaffrir Zor
Journal:  Immunol Lett       Date:  2015-12-03       Impact factor: 3.685

Review 4.  A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients.

Authors:  M Z Ratajczak; C H Kim; A Abdel-Latif; G Schneider; M Kucia; A J Morris; M J Laughlin; J Ratajczak
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

5.  Bioactive Sphingolipids and Complement Cascade as New Emerging Regulators of Stem Cell Mobilization and Homing.

Authors:  Mariusz Z Ratajczak; Chihwa Kim
Journal:  J Stem Cell Res Ther       Date:  2011-03-30

6.  Caged ceramide 1-phosphate analogues: synthesis and properties.

Authors:  Ravi S Lankalapalli; Alberto Ouro; Lide Arana; Antonio Gómez-Muñoz; Robert Bittman
Journal:  J Org Chem       Date:  2009-11-20       Impact factor: 4.354

7.  Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy.

Authors:  Gabriela Schneider; Ewa Bryndza; Ahmed Abdel-Latif; Janina Ratajczak; Magdalena Maj; Maciej Tarnowski; Yuri M Klyachkin; Peter Houghton; Andrew J Morris; Axel Vater; Sven Klussmann; Magdalena Kucia; Mariusz Z Ratajczak
Journal:  Mol Cancer Res       Date:  2013-04-24       Impact factor: 5.852

Review 8.  Ceramide and ceramide 1-phosphate in health and disease.

Authors:  Lide Arana; Patricia Gangoiti; Alberto Ouro; Miguel Trueba; Antonio Gómez-Muñoz
Journal:  Lipids Health Dis       Date:  2010-02-05       Impact factor: 3.876

9.  Ceramide 1-phosphate stimulates glucose uptake in macrophages.

Authors:  Alberto Ouro; Lide Arana; Patricia Gangoiti; Io-Guané Rivera; Marta Ordoñez; Miguel Trueba; Ravi S Lankalapalli; Robert Bittman; Antonio Gomez-Muñoz
Journal:  Cell Signal       Date:  2013-01-16       Impact factor: 4.315

10.  The ceramide-1-phosphate analogue PCERA-1 modulates tumour necrosis factor-alpha and interleukin-10 production in macrophages via the cAMP-PKA-CREB pathway in a GTP-dependent manner.

Authors:  Dorit Avni; Amir Philosoph; Michael M Meijler; Tsaffrir Zor
Journal:  Immunology       Date:  2009-11-16       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.